Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
4.260
-0.390 (-8.39%)
Oct 25, 2024, 4:00 PM EDT - Market closed
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $285.68 million as of October 25, 2024. Its market cap has increased by 293.49% in one year.
Market Cap
285.68M
Enterprise Value
62.64M
1-Year Change
293.49%
Ranking
Category
Stock Price
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $396.80M to $285.68M, a decrease of -28.00%. That is a compound annual growth rate of -9.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 25, 2024 | 285.70M | 284.01% |
Dec 29, 2023 | 74.40M | -23.69% |
Dec 30, 2022 | 97.50M | -64.90% |
Dec 31, 2021 | 277.80M | -29.99% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Kamada | 309.18M |
Zura Bio | 308.99M |
Monte Rosa Therapeutics | 308.68M |
Inozyme Pharma | 308.65M |
Design Therapeutics | 306.32M |
Spok Holdings | 303.72M |
AC Immune | 302.76M |
Jasper Therapeutics | 301.20M |